TABLE III.

First-line drug treatment patterns in 108 patients

Treatment	With radiotherapy [n (%)]		Overall
	No	Yes
Treatment regimens
Carboplatin	2 (2)	—	2 (2)
Carboplatin–docetaxel	—	1 (1)	1 (1)
Carboplatin–docetaxel–5FU	—	1 (1)	1 (1)
Carboplatin–5FU	1 (1)	—	1 (1)
Carboplatin–paclitaxel	1 (1)	—	1 (1)
Cetuximab	5 (5)	2 (2)	7 (6)
Cisplatin	32 (30)	16 (15)	48 (44)
Cisplatin–cetuximab	3 (3)	—	3 (3)
Cisplatin–docetaxel–	1 (1)	—	1 (1)
cetuximab
Cisplatin–docetaxel–5FU	7 (6)	3 (3)	10 (9)
Cisplatin–docetaxel–5FU	5 (5)	1 (1)	6 (6)
–cetuximab
Cisplatin–5FU	12 (11)	1 (1)	13 (12)
Cisplatin–5FU–cetuximab	—	1 (1)	1 (1)
Cisplatin–5FU	1 (1)	—	1 (1)
–methotrexate
Cisplatin–other	1 (1)	—	1 (1)
Cisplatin–paclitaxel	1 (1)	—	1 (1)
Docetaxel	2 (2)	—	2 (2)
Docetaxel–5FU –methotrexate	—	1 (1)	1 (1)
5FU–other	1 (1)	—	1 (1)
Gemcitabine	1 (1)	1 (1)	2 (2)
Methotrexate	2 (2)	1 (1)	3 (3)
Other	—	1 (1)	1 (1)
Regimen classa
Platinum-based	67 (62)	24 (22)	91 (84)
Cetuximab-based	14 (13)	4 (4)	18 (17)

^aNot mutually exclusive; regimen classes overlap. “Other” regimen assumed not to contain platinum or cetuximab.

5FU = 5-fluorouracil.